Safety, target engagement, and biomarker effects of bosutinib in dementia with Lewy bodies.
Alzheimers Dement (N Y)
; 8(1): e12296, 2022.
Article
in En
| MEDLINE
| ID: mdl-35662832
Full text:
1
Database:
MEDLINE
Type of study:
Clinical_trials
/
Qualitative_research
Language:
En
Year:
2022
Type:
Article